Clear Street Derivatives’s CERo Therapeutics Warrants CEROW Stock Holding History

Clear Street Derivatives’s Portfolio CEROW Stock Details CEROW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$6.38K	Hold	268,129	–	–	0.05%	21
2025 Q1	$3.89K	Hold	268,129	–	–	﹤0.01%	58
2024 Q4	$2.23K	Hold	268,129	–	–	﹤0.01%	73
2024 Q3	$1.37K	Hold	268,129	–	–	﹤0.01%	100
2024 Q2	$5.39K	Hold	268,129	–	–	﹤0.01%	90
2024 Q1	$18.3K	Buy	+268,129	New	+$16.3K	﹤0.01%	70

Other funds holding CEROW

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

QGA

Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

Clear Street Derivatives's CEROW Position: Q2 2025 in Review

Clear Street Derivatives held its CERo Therapeutics Warrants (CEROW) position steady in Q2 2025 at 268,129 shares worth $6.38K. The position accounts for 0.05% of the portfolio, ranked #21.

Clear Street Derivatives first reported a position in CEROW in Q1 2024 and has held it in 6 quarters since. The position peaked at $18.3K in Q1 2024. 23 funds tracked by Wall St. Rank hold CEROW as of Q2 2025.

Clear Street Derivatives held 268,129 shares of CERo Therapeutics Warrants worth $6.38K as of Q2 2025.
Clear Street Derivatives left its CERo Therapeutics Warrants share count unchanged in Q2 2025.
CERo Therapeutics Warrants made up 0.05% of Clear Street Derivatives's portfolio in Q2 2025, its #21 holding.
Clear Street Derivatives first reported a position in CERo Therapeutics Warrants in Q1 2024 and has held it in 6 quarters since.
Clear Street Derivatives's CERo Therapeutics Warrants position peaked at $18.3K in Q1 2024.
23 funds tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q2 2025.

Based on Clear Street Derivatives's 13F filing for Q2 2025, filed 13 Aug 2025.